SCHULTZE-SEEMANN, WOLFGANG et al
"Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study." Anticancer Research
39.2
(2019):
875-882.
Web. 11 May. 2026.
